212 related articles for article (PubMed ID: 24965167)
1. Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension.
Fujisaki K; Tsuruya K; Nakano T; Taniguchi M; Higashi H; Katafuchi R; Kanai H; Nakayama M; Hirakata H; Kitazono T;
Hypertens Res; 2014 Nov; 37(11):993-8. PubMed ID: 24965167
[TBL] [Abstract][Full Text] [Related]
2. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
3. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and effects on lipid metabolism of combination treatment with losartan + hydrochlorothiazide versus losartan + amlodipine: a 48-week prospective, multicenter, randomized, open-label trial.
Nishiwaki M; Hosoai H; Ikewaki K; Ayaori M; Yamashita T; Shige H; Higashi K; Nashida Y; Shimizu S; Kijima F; Yokoyama M; Nakamura H;
Clin Ther; 2013 Apr; 35(4):461-73. PubMed ID: 23490288
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[TBL] [Abstract][Full Text] [Related]
8. Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension--a prospective, randomized, open-labeled, parallel-group, multicenter trial.
Ueda T; Kai H; Imaizumi T;
Hypertens Res; 2012 Jul; 35(7):708-14. PubMed ID: 22399096
[TBL] [Abstract][Full Text] [Related]
9. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
[TBL] [Abstract][Full Text] [Related]
10. Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
Slagman MC; Waanders F; Vogt L; Damman K; Hemmelder M; Navis G; Laverman GD
Nephrol Dial Transplant; 2012 Mar; 27(3):983-90. PubMed ID: 21862455
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
Xue C; Zhou C; Yang B; Lv J; Dai B; Yu S; Wang Y; Zhao G; Mei C
BMJ Open; 2017 Feb; 7(2):e013672. PubMed ID: 28237959
[TBL] [Abstract][Full Text] [Related]
12. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
Suzuki H; Shimada Y; Fujiwara K
Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
Wu MT; Tung SC; Hsu KT; Lee CT
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of a fixed-dose combination of losartan/hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study.
Hosoya T; Kuriyama S; Ohno I; Kawamura T; Ogura M; Ikeda M; Ishikawa M; Hayashi F; Kanai T; Tomonari H; Soejima M; Akaba K; Tokudome G; Endo S; Fukui A; Gomi H; Hamaguchi A; Hanaoka K; Hara Y; Hara Y; Hasegawa T; Hayakawa H; Hikida M; Hirano K; Horiguchi M; Hosoya M; Ichida K; Imai T; Ishii T; Ishikawa H; Kameda C; Kasai T; Kobayashi A; Kobayashi H; Kurashige M; Kusama Y; Maezawa H; Maezawa Y; Maruyama Y; Matsuda H; Matsuo N; Matsuo T; Miura Y; Miyajima M; Miyakawa M; Miyazaki Y; Mizuguchi M; Nakao M; Nokano H; Ohkido I; Ohtsuka Y; Okada K; Okamoto H; Okonogi H; Saikawa H; Saito H; Sekiguchi C; Suetsugu Y; Sugano N; Suzuki T; Suzuki T; Takahashi H; Takahashi Y; Takamizawa S; Takane K; Morita T; Takazoe K; Tanaka H; Tanaka S; Terawaki H; Toyoshima R; Tsuboi N; Udagawa T; Ueda H; Ueda Y; Uetake M; Unemura S; Utsunomiya M; Utsunomiya Y; Yamada T; Yamada Y; Yamaguchi Y; Yamamoto H; Yokoo T; Yokoyama K; Yonezawa H; Yoshida H; Yoshida M; Yoshizawa T
Clin Exp Nephrol; 2012 Apr; 16(2):269-78. PubMed ID: 22127399
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease.
Hoshino T; Ookawara S; Miyazawa H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Yoshida I; Tabei K
Clin Exp Nephrol; 2015 Apr; 19(2):247-53. PubMed ID: 24821289
[TBL] [Abstract][Full Text] [Related]
17. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I
Arzneimittelforschung; 2012 Sep; 62(9):414-9. PubMed ID: 22773432
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of open-label losartan/hydrochlorothiazide combination therapy in Asian patients with hypertension not controlled with ACE inhibitor or ARB monotherapy.
Kim KS; Fan WH; Kim YD; Zhu W; Ngau YY; Tong P; Kim BS; Santos M; Lin WH; Buranakitjaroen P; Massaad R; Smith RD;
Hypertens Res; 2009 Jun; 32(6):520-6. PubMed ID: 19390542
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
